These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21159652)
1. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Wu DW; Cheng YW; Wang J; Chen CY; Lee H Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652 [TBL] [Abstract][Full Text] [Related]
2. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting. Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc. Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966 [TBL] [Abstract][Full Text] [Related]
4. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409 [TBL] [Abstract][Full Text] [Related]
5. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205 [TBL] [Abstract][Full Text] [Related]
6. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307 [TBL] [Abstract][Full Text] [Related]
7. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802 [TBL] [Abstract][Full Text] [Related]
8. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer. Pallier K; Houllier AM; Le Corre D; Cazes A; Laurent-Puig P; Blons H Mol Carcinog; 2009 Jul; 48(7):581-5. PubMed ID: 19353596 [TBL] [Abstract][Full Text] [Related]
9. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer. Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA signature predicts survival and relapse in lung cancer. Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer. Jiang H; Zhang H; Hu X; Li W Int J Biol Macromol; 2018 May; 111():623-631. PubMed ID: 29337100 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK; Kannisto E; Knudsen S; Yendamuri S Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859 [TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096 [TBL] [Abstract][Full Text] [Related]
15. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153 [TBL] [Abstract][Full Text] [Related]
19. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820 [TBL] [Abstract][Full Text] [Related]